Arthritis Care and Research

Applying the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Lupus Criteria to Patients From the LUMINA Cohort: Results From the Multiethnic, Multicenter US Cohort.  73:1451-1455. 2021

Epidemiology, Time Trends, and Outcomes of Serious Infections in Patients With Vasculitis: A Nineteen-Year National Study.  73:1544-1551. 2021

Development and validation of the juvenile spondyloarthritis disease flare (JSpAflare) measure: Ascertaining flare in patients with inactive disease. 2021

Influence of Multimorbidity on New Treatment Initiation and Achieving Target Disease Activity Thresholds in Active Rheumatoid Arthritis: A Cohort Study Using the Rheumatology Informatics System for Effectiveness (RISE) Registry. 2021

Disruptions in Rheumatology Care and the Rise of Telehealth in Response to the COVID-19 Pandemic in a Community Practice–Based Network.  73:1153-1161. 2021

Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis.  73:1114-1124. 2021

Achievement of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Criteria for Systemic Lupus Erythematosus and Amount of Damage Accrual: Results From a Multiethnic Multicenter Cohort.  73:1038-1040. 2021

Juvenile Spondyloarthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: High Biologic Use, Low Prevalence of HLA–B27, and Equal Sex Representation in Sacroiliitis.  73:940-946. 2021

Management of Rheumatic Diseases During the COVID-19 Pandemic: A National Veterans Affairs Survey of Rheumatologists.  73:998-1003. 2021

Association of Intermittent and Constant Knee Pain Patterns With Knee Pain Severity and With Radiographic Knee Osteoarthritis Duration and Severity.  73:788-793. 2021

Serious Infections in Patients With Gout in the US: A National Study of Incidence, Time Trends, and Outcomes.  73:898-908. 2021

Variability in Interpretation of Magnetic Resonance Imaging of the Pediatric Sacroiliac Joint.  73:841-848. 2021

Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women’s Rheumatoid Arthritis Sequential Study Registry.  73:471-480. 2021

Making Decisions About Stopping Medicines for Well-Controlled Juvenile Idiopathic Arthritis: A Mixed-Methods Study of Patients and Caregivers.  73:374-385. 2021

Discrete Choice Experiment on a Magnetic Resonance Imaging Scoring System for Temporomandibular Joints in Juvenile Idiopathic Arthritis. 2021

Low Incidence of Inflammatory Bowel Disease Adverse Events in Adalimumab Clinical Trials Across Nine Different Diseases.  73:289-295. 2021

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis 2021

Coronary Artery Disease in Adults With a History of Juvenile Arthritis.  72:1790-1793. 2020

Identifying Minimal and Meaningful Change in PROMIS® for Rheumatoid Arthritis: Use of Multiple Methods and Perspectives. 2020

What Does the Patient Global Health Assessment in Rheumatoid Arthritis Really Tell Us? Contribution of Specific Dimensions of Health-Related Quality of Life.  72:1571-1578. 2020

Gout flare severity from the patient perspective: a qualitative interview study. 2020

Performance of Administrative Algorithms to Identify Interstitial Lung Disease in Rheumatoid Arthritis.  72:1392-1403. 2020

Enhancing Patient Understanding of Medication Risks and Benefits. 2020

Relation of Patellofemoral Joint Alignment, Morphology, and Radiographic Osteoarthritis to Frequent Anterior Knee Pain: Data from the Multicenter Osteoarthritis Study.  72:1066-1073. 2020

Coexistent Hyperuricemia and Gout in Rheumatoid Arthritis: Associations With Comorbidities, Disease Activity, and Mortality.  72:950-958. 2020

Patient and Rheumatologist Perspectives Regarding Challenges to Achieving Optimal Disease Control in Rheumatoid Arthritis.  72:933-941. 2020

2020 American College of Rheumatology Guideline for the Management of Gout.  72:744-760. 2020

Imminent Fracture Risk: A Call to Action for Rheumatologists.  72:741-743. 2020

Reply.  72:736-738. 2020

2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.  72:461-488. 2020

Assessing Rheumatoid Arthritis Disease Activity With Patient-Reported Outcomes Measurement Information System Measures Using Digital Technology.  72:553-560. 2020

Comparative Risk of Cardiovascular Events With Biologic and Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.  72:561-576. 2020

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.  72:149-162. 2020

Do Patients With Moderate or High Disease Activity Escalate Rheumatoid Arthritis Therapy According to Treat-to-Target Principles? Results From the Rheumatology Informatics System for Effectiveness Registry of the American College of Rheumatology.  72:166-175. 2020

Association of Diabetes Mellitus and Biomarkers of Abnormal Glucose Metabolism With Incident Radiographic Knee Osteoarthritis.  72:98-106. 2020

Patterns and Correlates of Self-Management Strategies for Osteoarthritis-Related Pain Among Older Non-Hispanic Black and Non-Hispanic White Adults 2020

Step Rate and Worsening of Patellofemoral and Tibiofemoral Joint Osteoarthritis in Women and Men: The Multicenter Osteoarthritis Study.  72:107-113. 2020

Systematic Literature Review of Residual Symptoms and an Unmet Need in Patients With Rheumatoid Arthritis 2020

Variability in Glucocorticoid Prescribing for Rheumatoid Arthritis and the Influence of Provider Preference on Long-Term Use of Glucocorticoids 2020

2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures.  71:1540-1555. 2019

Association of Short-Term Ultraviolet Radiation Exposure and Disease Severity in Juvenile Dermatomyositis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.  71:1600-1605. 2019

International Consortium for Health Outcome Measurement Set of Outcomes That Matter to People Living With Inflammatory Arthritis: Consensus From an International Working Group.  71:1556-1565. 2019

Screening of Hyperlipidemia Among Patients With Rheumatoid Arthritis in the United States.  71:1593-1599. 2019

Sex Differences in Quality of Life in Patients With Systemic Lupus Erythematosus.  71:1647-1652. 2019

2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.  71:1285-1299. 2019

Association of Varus Knee Thrust During Walking With Worsening Western Ontario and McMaster Universities Osteoarthritis Index Knee Pain: A Prospective Cohort Study.  71:1353-1359. 2019

Low Persistence Rates in Patients With Rheumatoid Arthritis Treated With Triple Therapy and Adverse Drug Events Associated With Sulfasalazine.  71:1326-1335. 2019

Sex-Specific Influence of Quadriceps Weakness on Worsening Patellofemoral and Tibiofemoral Cartilage Damage: A Prospective Cohort Study.  71:1360-1365. 2019

Risk for Herpes Zoster in Tofacitinib-Treated Rheumatoid Arthritis Patients With and Without Concomitant Methotrexate and Glucocorticoids.  71:1249-1254. 2019

Thresholds in the Relationship of Quadriceps Strength With Functional Limitations in Women With Knee Osteoarthritis.  71:1186-1193. 2019

Timing of Abatacept Before Elective Arthroplasty and Risk of Postoperative Outcomes.  71:1224-1233. 2019

Concurrent Change in Quadriceps Strength and Physical Function Over Five Years in the Multicenter Osteoarthritis Study.  71:1044-1051. 2019

Long-Term Safety of Rituximab in Patients With Rheumatoid Arthritis: Results of a Five-Year Observational Study.  71:993-1003. 2019

Tocilizumab and the Risk of Cardiovascular Disease: Direct Comparison Among Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Patients.  71:1004-1018. 2019

Antinuclear Antibody–Negative Systemic Lupus Erythematosus in an International Inception Cohort.  71:893-902. 2019

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis.  71:703-716. 2019

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.  71:717-734. 2019

American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus.  71:579-590. 2019

Childhood arthritis and rheumatology research alliance consensus treatment plans for juvenile idiopathic arthritis–Associated and idiopathic chronic anterior uveitis.  71:482-491. 2019

Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout.  71:427-434. 2019

A Novel Method to Combine Assessment of Benefit and Harm: Outcome Measures in Rheumatology 3×3 Methodology Applied to Two Active Comparator Trials.  71:319-322. 2019

Chronic Inflammation in Rheumatoid Arthritis and Mediators of Skeletal Muscle Pathology and Physical Impairment: A Review.  71:173-177. 2019

Perspectives of Rheumatoid Arthritis Patients on Electronic Communication and Patient-Reported Outcome Data Collection: A Qualitative Study.  71:80-87. 2019

Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.  71:2-29. 2019

Clinical Characteristics and Factors Associated With Disability and Impaired Quality of Life in Children With Juvenile Systemic Sclerosis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.  70:1806-1813. 2018

Is Rheumatoid Arthritis a Cardiovascular Risk-Equivalent to Diabetes Mellitus?.  70:1694-1699. 2018

Occupational Therapy Treatment to Improve Upper Extremity Function in Individuals with Early Systemic Sclerosis: A Pilot Study.  70:1653-1660. 2018

Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.  70:1478-1487. 2018

Evaluation of a Methodologic Approach to Define an Inception Cohort of Rheumatoid Arthritis Patients Using Administrative Data.  70:1541-1545. 2018

Economic Evaluation of Lupus Nephritis in the Systemic Lupus International Collaborating Clinics Inception Cohort Using a Multistate Model Approach.  70:1294-1302. 2018

Development of the American College of Rheumatology Electronic Clinical Quality Measures for Gout.  70:659-671. 2018

Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis.  70:679-684. 2018

Toward Establishing a Standardized Magnetic Resonance Imaging Scoring System for Temporomandibular Joints in Juvenile Idiopathic Arthritis.  70:758-767. 2018

Affect and Incident Participation Restriction in Adults With Knee Osteoarthritis.  70:542-549. 2018

Delays to Care in Pediatric Lupus Patients: Data From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.  70:420-427. 2018

Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis.  70:409-419. 2018

Development and Pilot Testing of Multimedia Patient Education Tools for Patients With Knee Osteoarthritis, Osteoporosis, and Rheumatoid Arthritis.  70:213-220. 2018

Septic Arthritis in Emergency Departments in the US: A National Study of Health Care Utilization and Time Trends.  70:320-326. 2018

Perioperative Timing of Infliximab and the Risk of Serious Infection After Elective Hip and Knee Arthroplasty.  69:1845-1854. 2017

Gout Self-Management in African American Veterans: A Qualitative Exploration of Challenges and Solutions From Patients' Perspectives.  69:1724-1732. 2017

Serious Infections in Childhood-Onset Systemic Lupus Erythematosus: Using Administrative Claims Data to Investigate Disease Outcomes.  69:1617-1619. 2017

Risk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid Arthritis.  69:1526-1534. 2017

Calcium Pyrophosphate Deposition Disease and Associated Medical Comorbidities: A National Cross-Sectional Study of US Veterans.  69:1400-1406. 2017

2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.  69:1111-1124. 2017

Clinical Practice Guidelines: Incorporating Input From a Patient Panel.  69:1125-1130. 2017

Association of Anti–3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients.  69:1088-1094. 2017

Perceived Community Environmental Factors and Risk of Five-Year Participation Restriction Among Older Adults With or at Risk of Knee Osteoarthritis.  69:952-958. 2017

Knee Pain and Structural Damage as Risk Factors for Incident Widespread Pain: Data From the Multicenter Osteoarthritis Study.  69:826-832. 2017

Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid Arthritis.  69:313-322. 2017

Cost-Effectiveness Analysis of First-Line Treatment With Biologic Agents in Polyarticular Juvenile Idiopathic Arthritis.  68:1803-1811. 2016

Cost-Effectiveness of Triple Therapy Versus Etanercept Plus Methotrexate in Early Aggressive Rheumatoid Arthritis.  68:1751-1757. 2016

Mapping Perceptions of Lupus Medication Decision-Making Facilitators: The Importance of Patient Context.  68:1787-1794. 2016

Development of the American College of Rheumatology’s Rheumatoid Arthritis Electronic Clinical Quality Measures.  68:1579-1590. 2016

Effect of Knee Extensor Strength on Incident Radiographic and Symptomatic Knee Osteoarthritis in Individuals With Meniscal Pathology: Data From the Multicenter Osteoarthritis Study.  68:1640-1646. 2016

Are Pressure Time Integral and Cumulative Plantar Stress Related to First Metatarsophalangeal Joint Pain? Results From a Community-Based Study.  68:1232-1238. 2016

Treatment Algorithms for Patients with Systemic Lupus Erythematosus: Comment on the Article by Muangchan et al.  68:1385. 2016

Symptoms of Knee Instability as Risk Factors for Recurrent Falls.  68:1089-1097. 2016

Relation of Step Length to Magnetic Resonance Imaging-Detected Structural Damage in the Patellofemoral Joint: The Multicenter Osteoarthritis Study.  68:776-783. 2016

Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises.  68:667-672. 2016

Reply.  68:725-726. 2016

Enhanced Pain Sensitivity among Individuals with Symptomatic Knee Osteoarthritis: Potential Sex Differences in Central Sensitization.  68:472-480. 2016

Exercise Medicine for Osteoarthritis: Research Strategies to Maximize Effectiveness.  68:288-291. 2016

Incomplete Systemic Lupus Erythematosus: Early Diagnosis or Overdiagnosis?.  68:285-287. 2016

Longitudinal Course of Physical Function in People with Symptomatic Knee Osteoarthritis: Data from the Multicenter Osteoarthritis Study and the Osteoarthritis Initiative.  68:325-331. 2016

When Patients Write the Guidelines: Patient Panel Recommendations for the Treatment of Rheumatoid Arthritis.  68:26-35. 2016

Herpes Zoster Reactivation in Patients with Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease-Modifying Antirheumatic Drugs.  67:1671-1678. 2015

Can an intensive diet and exercise program prevent knee pain among overweight adults at high risk?.  67:965-971. 2015

20-Year-Old Amish Woman With Abdominal Pain, Retroperitoneal Mass, and Hyperlipidemia.  67:447-451. 2015

Proceedings from the American College of Rheumatology Reproductive Health Summit: The management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases.  67:313-325. 2015

Comprehensive appraisal of magnetic resonance imaging findings in sustained rheumatoid arthritis remission: A substudy.  67:929-939. 2015

Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients.  67:1345-1353. 2015

Does hospital volume predict outcomes and complications after total shoulder arthroplasty in the US?.  67:885-890. 2015

Electrocardiographic findings in systemic lupus erythematosus: Data from an international inception cohort.  67:128-135. 2015

Impact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients.  67:624-632. 2015

Novel method to collect medication adverse events in juvenile arthritis: Results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance project.  67:529-537. 2015

Racial and Ethnic Differences in Mortality and Cardiovascular Events among Patients with End-Stage Renal Disease Due to Lupus Nephritis.  67:1453-1462. 2015

Reply.  67:1041-1042. 2015

Rheumatoid arthritis is associated with higher ninety-day hospital readmission rates compared to osteoarthritis after hip or knee arthroplasty: A cohort study.  67:718-724. 2015

Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy.  67:731-736. 2015

What is the relationship between morning symptoms and measures of disease activity in patients with rheumatoid arthritis?.  67:1202-1209. 2015

Use of Oral and Subcutaneous Methotrexate in Rheumatoid Arthritis Patients in the United States.  66:1604-1611. 2014

Development and validation of the lupus impact tracker: A patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus.  66:1542-1550. 2014

Adding canakinumab to the childhood arthritis and rheumatology research alliance consensus treatment plans for systemic juvenile idiopathic arthritis: Comment on the article by DeWitt et al.  66:1430-1431. 2014

Changes in quality of life in the first 5 years of disease in a multicenter cohort of patients with systemic lupus erythematosus.  66:1374-1379. 2014

Daily walking and the risk of incident functional limitation in knee osteoarthritis: An observational study.  66:1328-1336. 2014

Complementary and alternative medicine use in African Americans with rheumatoid arthritis.  66:180-189. 2014

Development and retrospective validation of the juvenile spondyloarthritis disease activity index.  66:1775-1782. 2014

Imaging of the temporomandibular joint in juvenile idiopathic arthritis.  66:47-54. 2014

Linkage of a de-identified united states rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research.  66:1790-1798. 2014

Reply.  66:1271-1272. 2014

Risk of hospitalized bacterial infections associated with biologic treatment among US veterans with rheumatoid arthritis.  66:990-997. 2014

Socioeconomic disparities in the health of African Americans with rheumatoid arthritis from the southeastern United States.  66:1808-1817. 2014

Time trends in the characteristics of patients undergoing primary total knee arthroplasty.  66:897-906. 2014

Better functional and similar pain outcomes in osteoarthritis compared to rheumatoid arthritis after primary total knee arthroplasty: A cohort study.  65:1936-1941. 2013

Psychological profiles and pain characteristics of older adults with knee osteoarthritis.  65:1786-1794. 2013

Tumor necrosis factor, tuberculosis, testing, and treatment: Teeing up the questions.  65:1719-1721. 2013

Tumor necrosis factor, tuberculosis, testing, and treatment: teeing up the questions..  65:1719-1721. 2013

2013 Update of the 2011 American college of rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.  65:1551-1563. 2013

Patient perspectives on achieving treat-to-target goals: A critical examination of patient-reported outcomes.  65:1707-1712. 2013

Serum urate levels and consumption of common beverages and alcohol among chinese in Singapore.  65:1432-1440. 2013

Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases.  65:1085-1094. 2013

Sex and surgical outcomes and mortality after primary total knee arthroplasty: A risk-adjusted analysis.  65:1095-1102. 2013

Clinically important body weight gain following knee arthroplasty: A five-year comparative cohort study.  65:669-677. 2013

Reply.  65:832-833. 2013

Gout-related health care utilization in US emergency departments, 2006 through 2008.  65:571-577. 2013

Physicians' explanations for apparent gaps in the quality of rheumatology care: Results from the US Medicare Physician Quality Reporting System.  65:235-243. 2013

Preferences for arthritis interventions: Identifying similarities and differences among African Americans and whites with osteoarthritis.  65:203-211. 2013

Choosing wisely: The American College of Rheumatology's top 5 list of things physicians and patients should question.  65:329-339. 2013

Patient race and surgical outcomes after total knee arthroplasty: an analysis of a large regional database..  65:414-420. 2013

Trends in the use of biologic agents among rheumatoid arthritis patients enrolled in the US medicare program.  65:1743-1751. 2013

Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data.  64:1855-1863. 2012

Factors associated with gastrointestinal perforation in a cohort of patients with rheumatoid arthritis.  64:1819-1828. 2012

Serum cotinine as a biomarker of tobacco exposure and the association with treatment response in early rheumatoid arthritis.  64:1804-1810. 2012

Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity.  64:1794-1803. 2012

2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis..  64:1447-1461. 2012

2012 American college of rheumatology guidelines for management of gout. part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.  64:1431-1446. 2012

Reply.  64:1623-1624. 2012

Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study.  64:1462-1470. 2012

Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high-versus lower-risk rheumatoid arthritis patients.  64:1480-1489. 2012

Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy.  64:1282-1291. 2012

Adherence with intravenous zoledronate and intravenous ibandronate in the United States medicare population.  64:1054-1060. 2012

Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis.  64:1001-1010. 2012

Patterns of compartment involvement in tibiofemoral osteoarthritis in men and women and in whites and African Americans.  64:847-852. 2012

Rheumatoid arthritis disease activity measures: American college of rheumatology recommendations for use in clinical practice.  64:640-647. 2012

Incidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseases.  64:612-615. 2012

2012 update of the 2008 American college of rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.  64:625-639. 2012

Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort..  64:704-712. 2012

Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort.  64:132-137. 2012

Predicting future response to certolizumab pegol in rheumatoid arthritis patients: features at 12 weeks associated with low disease activity at 1 year..  64:658-667. 2012

Reply.  64:157-158. 2012

When it hurts, a positive attitude may help: Association of positive affect with daily walking in knee osteoarthritis. Results from a multicenter longitudinal cohort study.  64:1312-1319. 2012

Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice.  63:1680-1690. 2011

Thresholds in disease activity for switching biologics in rheumatoid arthritis patients: Experience from a large US cohort.  63:1672-1679. 2011

Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States.  63:1642-1653. 2011

Association of peptic ulcer disease and pulmonary disease with risk of periprosthetic fracture after primary total knee arthroplasty.  63:1471-1476. 2011

Changes in cotherapies after initiation of disease - Modifying antirheumatic drug therapy in patients with rheumatoid arthritis.  63:1415-1424. 2011

Quadriceps weakness, patella alta, and structural features of patellofemoral osteoarthritis.  63:1391-1397. 2011

Smoking as a risk factor for short-term outcomes following primary total hip and total knee replacement in veterans.  63:1365-1374. 2011

Reply.  63:1355. 2011

Reply.  63:1353. 2011

Decreased live births in women with systemic lupus erythematosus.  63:1068-1072. 2011

Disparities in post-acute rehabilitation care for joint replacement.  63:1020-1030. 2011

Patient understanding and satisfaction in informed consent for total knee arthroplasty: A randomized study.  63:1048-1054. 2011

Estimation of minimum clinically important difference for pain in fibromyalgia.  63:821-826. 2011

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features..  63:465-482. 2011

Defining quality of care in rheumatology: The American College of rheumatology white paper on quality measurement.  63:2-9. 2011

Measuring process of arthritis care: A proposed set of quality measures for the process of care in juvenile idiopathic arthritis.  63:10-16. 2011

Alpha 1-antitrypsin deficiency-related alleles Z and S and the risk of Wegener's granulomatosis.  62:3760-3767. 2010

Associations of cigarette smoking with rheumatoid arthritis in African Americans.  62:3560-3568. 2010

Most common single-nucleotide polymorphisms associated with rheumatoid arthritis in persons of European ancestry confer risk of rheumatoid arthritis in African Americans.  62:3547-3553. 2010

Converting modified Health Assessment Questionnaire (HAQ), multidimensional HAQ, and HAQII scores into original HAQ scores using models developed with a large cohort of rheumatoid arthritis patients.  62:1481-1488. 2010

A national survey of veterans affairs rheumatologists for relevance of quality of care indicators for gout management.  62:1306-1311. 2010

The independent effect of pain in one versus two knees on the presence of low physical function in a multicenter knee osteoarthritis study.  62:938-943. 2010

Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus.  62:881-887. 2010

Radiographic severity of rheumatoid arthritis in African Americans: Results from a multicenter observational study.  62:624-631. 2010

Report of the American College of Rheumatology Pain Management Task Force.  62:590-599. 2010

Development and initial validation of a self-assessed lupus organ damage instrument.  62:559-568. 2010

Reply.  62:581. 2010

Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort.  62:393-400. 2010

Physician preference motivates the use of anti-tumor necrosis factor therapy independent of clinical disease activity.  62:101-107. 2010

Value of assessing the fifth metatarsophalangeal joint in patients with early rheumatoid arthritis: Comment on the article by Sheane et al.  62:137. 2010

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis..  62:1515-1526. 2010

Association between patella alta and the prevalence and worsening of structural features of patellofemoral joint osteoarthritis: The multicenter osteoarthritis study.  62:1258-1265. 2010

Do worsening knee radiographs mean greater chances of severe functional limitation?.  62:1433-1439. 2010

Cartilage loss occurs in the same subregions as subchondral bone attrition: A within-knee subregion-matched approach from the multicenter osteoarthritis study.  61:1539-1544. 2009

Reply.  61:1615-1616. 2009

Skeletal health among African Americans with recent-onset rheumatoid arthritis.  61:1379-1386. 2009

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.  61:1168-1178. 2009

Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII.  61:1179-1186. 2009

Effect of thigh strength on incident radiographic and symptomatic knee osteoarthritis in a longitudinal cohort.  61:1210-1217. 2009

Novel evidence-based systemic lupus erythematosus responder index.  61:1143-1151. 2009

The effects of impaired joint position sense on the development and progression of pain and structural damage in knee osteoarthritis.  61:1070-1076. 2009

Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort.  61:830-839. 2009

Toward a Valid Definition of Gout Flare: Results of Consensus Exercises Using Delphi Methodology and Cognitive Mapping.  61:535-543. 2009

Is obesity a risk factor for progressive radiographic knee osteoarthritis?.  61:329-335. 2009

Rheumatology fellows' perception on training and careers in academia: The american college of rheumatology fellow research and academic training survey.  61:266-273. 2009

To the Editors.  61:285-286. 2009

Reply.  61:142. 2009

Optimal treatment of knee monarthritis in juvenile idiopathic arthritis: A decision analysis.  59:1580-1588. 2008

Association of body composition with disability in rheumatoid arthritis: Impact of appendicular fat and lean tissue mass.  59:1407-1415. 2008

Employment and disability issues in systemic lupus erythematosus: A review.  59:1475-1479. 2008

Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort.  59:1332-1340. 2008

Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: An American College of Rheumatology white paper.  59:1058-1073. 2008

Abnormal body composition phenotypes in older rheumatoid arthritis patients: Association with disease characteristics and pharmacotherapies.  59:807-815. 2008

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.  59:762-784. 2008

Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis.  59:746-753. 2008

Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study.  59:721-729. 2008

Accumulation of coronary artery disease risk factors over three years: Data from an international inception cohort.  59:176-180. 2008

Association of health-related quality of life with dual use of prescription and over-the-counter nonsteroidal antiinflammatory drugs.  59:227-233. 2008

Comparison of Vancouver and International League of Associations for Rheumatology classification criteria for juvenile psoriatic arthritis.  59:51-58. 2008

Measurement of fatigue in systemic lupus erythematosus: A systematic review.  57:1348-1357. 2007

Racial/ethnic disparities in patient-reported nonsteroidal antiinflammatory drug (NSAID) risk awareness, patient-doctor NSAID risk communication, and NSAID risk behavior.  57:1539-1545. 2007

Absence of histologic evidence of synovitis in patients with Gulf War veterans' illness with joint pain.  57:1316-1323. 2007

Classification criteria in rheumatic diseases: A review of methodologie properties.  57:1119-1133. 2007

Using the short form 6D, as an overall measure of health, to predict damage accrual and mortality in patients with systemic lupus erythematosus: XLVII, results from a multiethnic US cohort.  57:986-992. 2007

Quality of care for gout in the US needs improvement.  57:822-829. 2007

A multiethnic, multicenter cohort of patients with Systemic Lupus Erythematosus (SLE) as a model for the study of ethnic disparities in SLE.  57:576-584. 2007

Accuracy of the diagnoses of spondylarthritides in veterans affairs medical center databases.  57:648-655. 2007

Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor α antagonists and disease-modifying antirheumatic drugs.  57:343-346. 2007

Contributions of OMERACT to rheumatic disease research [1].  57:186. 2007

Validity of gout diagnoses in administrative data.  57:103-108. 2007

Osteoporosis in the home health care setting: A window of opportunity?.  55:971-975. 2006

Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: Association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.  55:799-806. 2006

Durometry for the assessment of skin disease in systemic sclerosis.  55:603-609. 2006

Development of classification and response criteria for rheumatic diseases.  55:348-352. 2006

Population-based assessment of adverse events associated with long-term glucocorticoid use.  55:420-426. 2006

Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis.  55:333-337. 2006

Race/ethnicity and cancer occurrence in systemic lupus erythematosus.  53:781-784. 2005

Are health care professionals advising adults with arthritis to become more physically active?.  53:279-283. 2005

Accuracy of veterans administration databases for a diagnosis of rheumatoid arthritis.  51:952-957. 2004

Systemic lupus erythematosus in three ethnic groups. XIX. Natural history of the accrual of the American College of Rheumatology criteria prior to the occurrence of criteria diagnosis.  51:609-615. 2004

Measuring quality in arthritis care: The arthritis foundation's quality indicator set for analgesics.  51:337-349. 2004

Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course.  51:465-474. 2004

Measuring Quality in Arthritis Care: Methods for Developing the Arthritis Foundation's Quality Indicator Set.  51:193-202. 2004

Systemic Lupus Erythematosus in Three Ethnic Groups. XVIII. Factors Predictive of Poor Compliance with Study Visits.  51:258-263. 2004

Systemic Lupus Erythematosus in Three Ethnic Groups. XIV. Poverty, Wealth, and Their Influence on Disease Activity.  51:73-77. 2004

Leflunomide Use during the First 33 Months after Food and Drug Administration Approval: Experience with a National Cohort of 3,325 Patients.  49:745-751. 2003

The effects of physician specialty and patient comorbidities on the use and discontinuation of coxibs.  49:293-299. 2003

A reply to comments on sociocultural issues in clinical research: Unraveling the Tuskegee Syphilis Study [1].  47:691. 2002

Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: A comparison of physician and patient visual analog scale scores.  47:408-413. 2002

Systemic lupus erythematosus in three ethnic groups. X. Measuring cognitive impairment with the cognitive symptoms inventory.  47:310-319. 2002

Psychosocial and health status variables independently predict health care seeking in fibromyalgia.  45:362-371. 2001

Resolved: Low-dose glucocorticoids are neither safe nor effective for the long-term treatment of rheumatoid arthritis.  45:468-471. 2001

Sociocultural issues in clinical research.  45:203-207. 2001

Systemic lupus erythematosus in three ethnic groups. VIII. Predictors of early mortality in the LUMINA cohort.  45:191-202. 2001

Use of complementary and alternative medicine by older patients with arthritis: A population-based study.  45:398-403. 2001

Systemic lupus erythematosus in three ethnic groups. IV. Factors associated with self-reported functional outcome in a large cohort study.  12:256-266. 1999

Systemic lupus erythematosus in three ethnic groups. V. Acculturation, health-related attitudes and behaviors, and disease activity in hispanic patients from the LUMINA cohort.  12:267-276. 1999